Back to News
Market Impact: 0.22

Better Artificial Intelligence (AI) Stock to Buy: SpaceX vs. Nvidia

Artificial IntelligenceTechnology & InnovationCorporate EarningsCompany FundamentalsAnalyst InsightsMarket Technicals & FlowsPrivate Markets & VentureM&A & Restructuring
Better Artificial Intelligence (AI) Stock to Buy: SpaceX vs. Nvidia

The article argues Nvidia is the better AI stock versus SpaceX, citing Nvidia's 85% latest-quarter revenue growth and projected 96% current-quarter growth versus SpaceX's 22% AI-division revenue growth. It also notes Nvidia's far larger profitability, with over $250 billion in trailing revenue and about $160 billion in net income, compared with SpaceX's under $20 billion in 2025 revenue and $6.6 billion in adjusted EBITDA. Overall, the piece favors Nvidia on AI business quality and valuation, while acknowledging SpaceX's broader business diversification.

Analysis

The key portfolio implication is not that one mega-cap is “better” than another, but that AI capex leadership is becoming bifurcated: one name monetizes the compute bottleneck directly, while the other is effectively a broader venture stack with a high-beta optionality embedded in a much larger ecosystem. That matters because when growth decelerates even modestly, the market typically compresses multiple differently for pure infrastructure winners versus conglomerate-style platforms; the former can keep compounding through order visibility, the latter becomes hostage to execution across several businesses.

The second-order effect is that the strongest beneficiary of AI demand remains the one with the cleanest re-investment loop. If hyperscaler spend stays elevated, GPU suppliers should continue to enjoy both pricing power and faster inventory digestion than anything tied to consumer-adjacent monetization. By contrast, the more diversified platform may still win on strategic optionality, but that optionality is harder to underwrite in public markets until it shows up as sustained free cash flow, not just narrative value.

The contrarian point is that the “reasonable valuation” argument can flip quickly if growth normalizes even slightly. For a market darling with a very large installed base, a 10-15 point growth deceleration over the next 1-2 quarters can take the stock from “cheap for its growth” to “fully priced” in one earnings cycle. The bigger risk is not outright demand collapse; it is any sign that supply chain expansion catches up faster than end-demand, which would reduce scarcity value and make the multiple vulnerable before fundamentals visibly roll over.

More News